Impact of Glucagon-Like Peptide-1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population-Based Longitudinal Cohort Study
Tinas aim is not just to ameliorate the symptoms of the condition, but to address the root of the problem
GLP-1 agonists are chemically derived peptides that work to: activate GLP-1 receptors Enhance insulin production Decrease glucagon secretion Delay gastric emptying Act on brain pathways to regulate appetite and satiety These combined effects support improved glucose metabolism, reduced appetite, and better overall metabolic function What is Tirzepatide and how is it different
Its another tool to help with living a healthy lifestyle, and like any other tool, it works well if used properly, says Ali
References Raun K, Hansen BS, Johansen NL, Thgersen H, Madsen K, Ankersen M, Andersen PH